Hunniwell Lake Ventures Spotlights NuvOxNuvOx PharmaJul 15, 20201 min readHunniwell Lake Ventures interviews NuvOx Co-founder and CEO, Evan Unger MD.See the interview
NuvOx Announces Receipt of IND for Study of NanO2 as Cardioprotectant in Acute Myocardial InfarctionNuvOx Announces Receipt of IND for Study of NanO2 as Cardioprotectant in Acute Myocardial Infarction Tucson, AZ – March 4, 2025 - NuvOx...
NuvOx Announces MHRA Approval to Commence Phase IIb Stroke TrialTucson, AZ – January 21,2025 - NuvOx Therapeutics, Inc. (“NuvOx”) announced that The Medicines and Healthcare products Regulatory Agency...
NuvOx Announces Two New PublicationsNuvOx Announces Two New Publications Tucson, AZ – October 21, 2024 - Co-Founders, Dr. Evan Unger and Dr. Jennifer LH Johnson combine...
Kommentarer